BATRA · Atlanta Braves Holdings, Inc. · Insider Trading

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on June 30, 2026.

Reflects the weighted average sale price. The range of prices for such transaction is $52.41 to $54.10. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on June 30, 2026.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on June 30, 2026.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on June 30, 2026.

Reflects the weighted average sale price. The range of prices for such transaction is $53.64 to $54.22. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 18, 2026.

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 18, 2026.

Reflects the weighted average sale price. The range of prices for such transaction is $52.24 to $53.66. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

These shares are owned by Associated Capital Group, Inc.

On February 25, 2026, the Reporting Person acquired 10,868 shares of the Issuer's Series B Common Stock in a private transaction from two trusts, the beneficiaries of which are his adult children. In exchange for these shares, the Reporting Person contributed to the trusts an aggregate of 14,614 shares of the Issuer's Series C Common Stock along with $42.18 in cash.

Each share of Series B Common Stock is convertible, at the holder's election, into one share of Series A Common Stock, at any time for no consideration other than the surrender of the share of Series B Common Stock for each share of Series A Common Stock.

On February 25, 2026, the Reporting Person acquired 10,868 shares of the Issuer's Series B Common Stock in a private transaction from two trusts, the beneficiaries of which are his adult children. In exchange for these shares, the Reporting Person contributed to the trusts an aggregate of 14,614 shares of the Issuer's Series C Common Stock along with $42.18 in cash.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 15, 2025.

Reflects the weighted average sale price. The range of prices for such transaction is $43.66 to $44.74. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

Each share of Series B Common Stock is convertible, at the holder's election, into one share of Series A Common Stock, at any time for no consideration other than the surrender of the share of Series B Common Stock for each share of Series A Common Stock.

Shares purchased in a private transaction, not on the open market.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 15, 2025.

Reflects the weighted average sale price. The range of prices for such transaction is $39.71 to $40.22. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units.

Reflects the weighted average sale price. The range of prices for such transaction is $39.37 to $40.12. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units.

Reflects the weighted average sale price. The range of prices for such transaction is $39.37 to $40.12. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

The sale reported on this Form 4 represents shares sold by the reporting person in part to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units.

Reflects the weighted average sale price. The range of prices for such transaction is $39.36 to $40.12. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units.

Reflects the weighted average sale price. The range of prices for such transaction is $39.37 to $40.12. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units.

Reflects the weighted average sale price. The range of prices for such transaction is $39.41 to $40.04. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 15, 2025 and was intended to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units.

Reflects the weighted average sale price. The range of prices for such transaction is $39.37 to $40.12. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

Each restricted stock unit converted into one share of Series C Common Stock.

Each restricted stock unit converted into one share of Series C Common Stock.

Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock.

One-third of the restricted stock unit award vested on each of December 11, 2024 and 2025, and the remaining restricted stock units vest on December 11, 2026.

Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock.

One-third of the restricted stock unit award vested on each of December 11, 2024 and 2025, and the remaining restricted stock units vest on December 11, 2026.

Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock.

One-third of the restricted stock unit award vested on each of December 11, 2024 and 2025, and the remaining restricted stock units vest on December 11, 2026.

Each restricted stock unit converted into one share of Series C Common Stock.

Each restricted stock unit converted into one share of Series C Common Stock.

Each restricted stock unit converted into one share of Series C Common Stock.

Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock.

One-third of the restricted stock unit award vested on each of December 11, 2024 and 2025, and the remaining restricted stock units vest on December 11, 2026.

Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock.

One-third of the restricted stock unit award vested on each of December 11, 2024 and 2025, and the remaining restricted stock units vest on December 11, 2026.

Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock.

One-third of the restricted stock unit award vested on each of December 11, 2024 and 2025, and the remaining restricted stock units vest on December 11, 2026.

Each restricted stock unit converted into one share of Series C Common Stock.

The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units.

Reflects the weighted average sale price. The range of prices for such transaction is $38.29 to $38.77. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units.

Reflects the weighted average sale price. The range of prices for such transaction is $38.57 to $38.79. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units.

Reflects the weighted average sale price. The range of prices for such transaction is $38.43 to $38.81. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units.

Reflects the weighted average sale price. The range of prices for such transaction is $38.29 to $38.77. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 15, 2025 and was intended to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units.

Reflects the weighted average sale price. The range of prices for such transaction is $38.31 to $38.93. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units.

Reflects the weighted average sale price. The range of prices for such transaction is $38.31 to $38.76. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock.

Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock.

Each restricted stock unit converted into one share of Series C Common Stock.

Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock.

Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock.

Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock.